Home › Funds › NorthCoast Asset Management LLC › VRTX

NorthCoast Asset Management LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

NorthCoast Asset Management LLC reported holding 95,246 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$47.3M, representing 1.05% of its reported portfolio and ranking #19 among its reported holdings. NorthCoast Asset Management LLC has disclosed VRTX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)95.25K sh
Reported value held$47.31M
Portfolio Weight1.05%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How NorthCoast Asset Management LLC's VRTX position evolved

NorthCoast Asset Management LLC first disclosed a stake in VRTX in Q1 2024 at 1,602 shares (US$670K). The position peaked in Q2 2026 at 95,246 shares, worth US$47.3M. Across 10 filings, NorthCoast Asset Management LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 95,246 shares valued at US$47.3M — an increase of 4,361 shares quarter over quarter.. Notable position changes include a 1863% increase in Q2 2024 (shares were roughly flat over the following quarter), a 278% increase in Q2 2025 (shares fell 12% over the following quarter), a 151% increase in Q3 2025 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 1.60K $669.65K New
Q2 2024 31.45K $14.74M Add
Q3 2024 36.08K $15.43M Add
Q4 2024 17.18K $6.92M Reduce
Q1 2025 8.47K $4.11M Reduce
Q2 2025 32.04K $14.27M Add
Q3 2025 80.59K $31.56M Add
Q4 2025 98.38K $44.60M Add
Q1 2026 90.89K $40.58M Reduce
Q2 2026 95.25K $47.31M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has NorthCoast Asset Management LLC held VRTX?

NorthCoast Asset Management LLC has disclosed VRTX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is NorthCoast Asset Management LLC's current position in VRTX?

As of Q2 2026, NorthCoast Asset Management LLC holds 95.25K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $47.31M, representing 1.05% of its reported portfolio and ranking #19.

Has NorthCoast Asset Management LLC been buying or selling VRTX?

In the latest 13F filing (Q2 2026), NorthCoast Asset Management LLC increased its position in VRTX. The position peaked in Q2 2026 at 95.25K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.